Inno Biologics has delivered the first batch of clinical grade biopharma material made in Malaysia and entered into its first agreement to commercially manufacture biosimilars for Avesthagen Ltd., a life science company based in India. Dr. Mohd Nazlee Kamal, group managing director of Inno Bio Ventures, said, “This accomplishment is a reflection of the propensity and capacity of the Group to pioneer Malaysia’s foray into the global biotechnology arena. To be chosen to undertake this complex p...